All websites

Some 6,000 employees and former employees have subscribed for 491,502 shares totalling €31.5 million as part of the capital increase operation reserved for Arkema employees, which has just closed. Setting yet another record in terms of amount invested and number of participants, this latest operation is a reflection of the employees’ confidence in their Group’s strategy and prospects.

Six years after its initial operation, and with a desire to keep on involving its employees and former employees closely in its successes, Arkema conducted a fourth share capital increase on 23 April 2014. This involved some 6,000 subscribers from 20 countries around the world. The employee participation rate reached 41% on average in the world, i.e. almost 5 points more than with the previous operation in 2012, and 63% in France, i.e. 9 points more than in 2012.

The subscription period spanned 7 to 20 March 2014. The subscription price was set at €64.19 per share by the Board of Directors meeting on 3 March 2014; this corresponds to the average opening price of the Arkema share quoted on the Paris stock exchange in the last 20 trading days prior to the date of this Board of Directors meeting, minus a 20% discount.

Arkema’s share capital has increased to €635,211,940, divided into 63,521,194 shares. At the close of the operation, the share of Arkema’s capital held by its employees stands at some 4.7%.

The newly issued shares will be fully comparable to existing shares, and will bear interest from 1st January 2013, with entitlement to dividends for the year ended 31 December 2013.

 

 

A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of some €6.1 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands. 

Contacts

Top